Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021

SELL
$99.61 - $142.12 $199,220 - $284,240
-2,000 Closed
0 $0
Q3 2020

Oct 27, 2020

BUY
$72.92 - $102.01 $145,840 - $204,020
2,000 New
2,000 $204,000
Q4 2019

Jan 24, 2020

SELL
$77.66 - $99.74 $1.05 Million - $1.35 Million
-13,500 Closed
0 $0
Q1 2019

Apr 26, 2019

SELL
$61.98 - $96.5 $12,396 - $19,300
-200 Reduced 1.46%
13,500 $1.17 Million
Q4 2018

Feb 06, 2019

SELL
$56.04 - $82.66 $23,817 - $35,130
-425 Reduced 3.01%
13,700 $864,000
Q1 2018

May 03, 2018

BUY
$39.82 - $57.53 $79,640 - $115,060
2,000 Added 16.49%
14,125 $570,000
Q3 2017

Nov 02, 2017

BUY
$37.05 - $47.12 $449,231 - $571,330
12,125
12,125 $571,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Nicolet Bankshares Inc Portfolio

Follow Nicolet Bankshares Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Bankshares Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Bankshares Inc with notifications on news.